Pancrelipase (Creon)


FDA Approved Indications:
  • Exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions
Prior authorization criteria:
  • Medical record documentation required confirming diagnosis, AND
  • Dosing is appropriate based on patient's diagnosis, age and weight
The following conditions do not meet criteria for use established by the Western Health Advantage Pharmacy and Therapeutics Committee:
  • Malabsorption syndrome
  • Dietary aid
  • 1 year
WHA is closely monitoring the Coronavirus Disease 2019 (COVID-19). Learn more about COVID-19.